Kura Oncology, Inc. (KURA) Ownership

$8.51

south_east
-$0.22 (-2.52%)
Day's range
$8.51
Day's range
$8.88

Kura Oncology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.93 M $69.11 M   10.88% 9.12%
ARMISTICE CAPITAL, LLC 02/14/2025 5.80 M $50.52 M   118.21% 6.67%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 5.08 M $44.22 M   -33.67% 5.84%
VANGUARD GROUP INC 02/11/2025 4.82 M $41.97 M   14.64% 5.54%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 4.45 M $38.77 M   100.00% 5.12%
ECOR1 CAPITAL, LLC 02/14/2025 3.56 M $30.98 M   -38.74% 4.09%
BVF INC/IL 02/14/2025 2.57 M $22.36 M   -23.85% 2.95%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.37 M $20.62 M   180.07% 2.72%
AVORO CAPITAL ADVISORS LLC 02/14/2025 2.25 M $19.60 M   -36.47% 2.59%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.78 M $15.53 M   0.09% 2.05%
FORESITE CAPITAL MANAGEMENT IV, LLC 02/14/2025 1.73 M $15.04 M   -6.65% 1.99%
FRANKLIN RESOURCES INC 02/12/2025 1.54 M $13.40 M   -3.14% 1.77%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.43 M $12.42 M   35.32% 1.64%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 1.42 M $12.40 M   0.00% 1.64%
SIREN, L.L.C. 02/14/2025 1.34 M $11.67 M   0.00% 1.54%
PROSIGHT MANAGEMENT, LP 02/14/2025 1.33 M $11.54 M   87.91% 1.52%
D. E. SHAW & CO., INC. 02/14/2025 1.15 M $10.03 M   172.02% 1.32%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 1.12 M $9.72 M   982.52% 1.28%
MARSHALL WACE, LLP 02/13/2025 948,905 $8.26 M   100.00% 1.09%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 905,184 $7.88 M   -13.96% 1.04%
ALGERT GLOBAL LLC 02/14/2025 883,703 $7.70 M   224.56% 1.02%
GOLDMAN SACHS GROUP INC 02/11/2025 863,085 $7.52 M   21.65% 0.99%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/12/2025 694,387 $6.05 M   100.00% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 635,494 $5.54 M   1.69% 0.73%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 610,087 $5.31 M   0.00% 0.70%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 597,810 $5.21 M   463.39% 0.69%
TREXQUANT INVESTMENT LP 02/12/2025 566,945 $4.94 M   867.76% 0.65%
ALETHEA CAPITAL MANAGEMENT, LLC 02/14/2025 558,442 $4.86 M   0.89% 0.64%
WALLEYE CAPITAL LLC 02/13/2025 536,318 $4.67 M   -6.13% 0.62%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 448,368 $3.91 M   9.80% 0.52%
CANDRIAM S.C.A. 02/07/2025 422,652 $3.68 M   -53.37% 0.49%
JPMORGAN CHASE & CO 02/12/2025 365,921 $3.19 M   -10.59% 0.42%
1492 CAPITAL MANAGEMENT LLC 02/13/2025 342,598 $2.98 M   367.88% 0.39%
UBS GROUP AG 02/14/2025 315,475 $2.75 M   143.02% 0.36%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 02/13/2025 314,526 $2.74 M   88.88% 0.36%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 298,662 $2.60 M   18.16% 0.34%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 297,234 $2.59 M   440.71% 0.34%
VOSS CAPITAL, LLC 02/13/2025 275,000 $2.40 M   100.00% 0.32%
TWO SIGMA ADVISERS, LP 02/14/2025 242,200 $2.11 M   147.15% 0.28%
JUMP FINANCIAL, LLC 02/13/2025 239,933 $2.09 M   862.04% 0.28%
HOLOCENE ADVISORS, LP 02/14/2025 226,895 $1.98 M   -91.56% 0.26%
BANK OF NEW YORK MELLON CORP 02/04/2025 202,941 $1.77 M   -1.33% 0.23%
BARCLAYS PLC 02/13/2025 201,864 $1.76 M   21.98% 0.23%
FMR LLC 02/13/2025 184,428 $1.61 M   113.38% 0.21%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 182,668 $1.59 M   -28.89% 0.21%
WOODLINE PARTNERS LP 02/14/2025 172,704 $1.50 M   20.60% 0.20%
TWO SIGMA INVESTMENTS, LP 02/14/2025 166,119 $1.45 M   -20.23% 0.19%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 163,559 $1.42 M   969.92% 0.19%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 157,959 $1.38 M   100.00% 0.18%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/14/2025 150,000 $1.31 M   100.00% 0.17%

Kura Oncology, Inc. institutional Ownership - FAQ's

During the previous two years, 246 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 7.93 M

ARMISTICE CAPITAL, LLC: 5.8 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 5.08 M

VANGUARD GROUP INC: 4.82 M

RA CAPITAL MANAGEMENT, L.P.: 4.45 M

EcoR1 Capital, LLC: 3.56 M

90.77% of Kura Oncology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 82.66 M shares in the last 24 months. This purchase volume represents approximately $703.47 M in transactions.